Dow Inc. (DOW) | The Buildout — AI Infrastructure
The Verdict
Dow is a global materials science company whose three segments make packaging and specialty plastics, industrial intermediates and infrastructure, and performance materials and coatings. In the AI infrastructure buildout, its clearest role is supplying thermal management materials and service models for data-center cooling, plus silicones used in electronics and data-center applications. That exposure is real but embedded and not a reported financial line.
| Market Cap | — |
| Revenue (TTM) | $41.3B |
| Revenue Growth | −1.2% |
| EBITDA Margin (TTM) | 6.6% |
| Net Debt | $16.9B |
| Earnings Beats | 4 of 5 |
| P/E (TTM) | — |
| EV/EBITDA (TTM) | — |
What We Like
- Q2 2026 operating EBITDA hit $2.3 billion, above the original ~$2.0 billion guide and the referenced ~$2.2 billion intra-quarter update.
- 2026 self-help target raised to more than $1.3 billion; Transform to Outperform in-year benefit raised to ~$700 million.
- More than 60% of Dow's assets sit in feedstock-advantaged regions, and Q2 P&SP local price rose more than 40% YoY.
- Data-center demand is outpacing supply by management's description; Dow pairs closed-loop liquid cooling, thermal fluids, and acoustic materials with the Coolant Care Network service model.
- Barry shutdown removed about 25% of European siloxane capacity and is expected to add $60 million of H2 2026 EBITDA.
What We’re Watching
- Sadara restructuring remains unresolved; cash commitments run ~$100 million per year from 2026 through 2038.
- Supply disruption duration is management's 6-18 month base case, with a 275+-day unwind model; faster reopening could reverse pricing.
- Q2 II&I strength included competitor MDI/PO outages and a ~$50 million Taiwan land sale; the Q3 guide assumes normalization.
- Transform to Outperform's $2 billion total is described both as 'by the end of next year' and 'by 2028' on the Q2 call.
The execution thesis is strengthening: Q1 and Q2 guidance were beaten, self-help targets were raised twice, and asset actions were completed on schedule. The broader earnings story, though, remains tied to a conflict-driven supply shock and not yet to disclosed AI demand. The open question is whether the margin step-change can survive faster supply normalization.
Earnings Beat
Q2 2026 net sales were $12.1 billion, up 20% year over year, and operating EBITDA was $2.3 billion, above the original ~$2.0 billion guide. Gross margin was 17.9%. P&SP net sales rose 27% YoY on local price up more than 40% YoY; II&I operating EBIT was $246 million and PM&C operating EBIT was $133 million.
| Metric | Q2 FY2026 | Q1 FY2026 | Q2 FY2025 | YoY |
|---|---|---|---|---|
| Revenue | $12.1B | $9.8B | $10.1B | +19.7% |
| Gross margin | 17.9% | 6.5% | 5.4% | +1250bps |
| EBITDA | $1.5B | $688M | $733M | +110.9% |
| EPS | $1.02 | $-0.62 | $-1.18 | −185.8% |
| P&SP local price YoY | >40% | n/a | n/a | Up >40% YoY |
We are not waiting for conditions to turn in our favor. We are leading with deliberate actions and controlling what we can control.— Karen S. Carter, Chief Executive Officer, July 23, 2026
Management tone: Management's tone stayed confident and execution-focused on Carter's first call as CEO. Leadership gave direct answers on the P&SP segment miss, the Sadara volume drag, buybacks, and the conservative Q3 guide, while repeatedly emphasizing 'controlling what we can control'.
Management Guidance
Management guided Q3 2026 operating EBITDA to ~$1.7 billion, assuming a $0.10/lb decline in global integrated polyethylene margins versus Q2, no additional quarterly price movement, and normalization of competitor MDI/PO outages. Fiscal 2026 self-help was raised to more than $1.3 billion, Transform to Outperform's in-year benefit to ~$700 million, and H2 working capital release is expected to exceed $500 million; no buybacks are expected in 2026.
Trajectory
Revenue trajectory is accelerating off a low base: Q1 2026 revenue was $9,794M and Q2 2026 was $12,092M, a 23.5% sequential gain. Gross margin swung from 6.5% in Q1 to 17.9% in Q2. The jump is mostly price-driven from Middle East supply disruption, led by P&SP local price up more than 40% YoY and over $300 million of Q2 self-help; the computed signals still label four-quarter average revenue growth negative and the earnings bar hard.
The Model
The model's locked projections are FY+1 revenue of $46,800M with EBITDA of $7,722M (16.5% margin), and FY+2 revenue of $44,800M with EBITDA of $7,213M (16.1% margin). The FY+1 step-up is anchored to supply-disruption pricing and self-help momentum; FY+2 eases revenue while holding the EBITDA margin near the FY+1 level.
| Metric | FY2025 | Next FY (E) | Following FY (E) |
|---|---|---|---|
| Revenue | $40.0B | $46.8B | $44.8B |
| YoY Growth | — | +17.1% | −4.3% |
| EBITDA | $2.1B | $7.7B | $7.2B |
| EBITDA Margin | 5.2% | 16.5% | 16.1% |
Projections are the median of 5 independent model runs. The model’s revenue sits 0.2% below analyst consensus.
Management guided Q3 2026 operating EBITDA to ~$1.7 billion, assuming a $0.10/lb decline in global integrated polyethylene margins versus Q2, no additional quarterly price movement, and normalization of competitor MDI/PO outages. Fiscal 2026 self-help was raised to more than $1.3 billion, Transform to Outperform's in-year benefit to ~$700 million, and H2 working capital release is expected to exceed $500 million; no buybacks are expected in 2026.
What Could Go Right — and Wrong
- Middle East supply constraints persist into 2027, keeping the 6-18 month disruption window from narrowing.
- The $0.05/lb North American polyethylene increase sticks, and China restocking continues, delivering upside to the Q3 guide.
- Data-center thermal management becomes a disclosed, measurable revenue line as the Coolant Care Network scales.
- Sadara restructuring completes on terms that cap or end the ~$100 million per year cash commitment.
- Transform to Outperform keeps overdelivering; the new quarterly headcount disclosures confirm productivity gains.
- Strait of Hormuz reopens or petrochemical flows normalize faster than the 275+-day unwind model, collapsing pricing.
- April $0.30/lb and May $0.20/lb PE increases trigger demand destruction in Dow's order books.
- Competitor MDI/PO capacity returns faster than expected, removing the II&I spread support that offset Q2's P&SP miss.
- Sadara restructuring stalls or fails, leaving guarantees and the long-dated cash obligations in place.
- Credit pressure builds if earnings fall without debt paydown; management's first priority is debt paydown, with no buybacks expected in 2026.
Looking Ahead
The next twelve months hinge on whether the supply-driven pricing umbrella lasts long enough for self-help and asset actions to build a higher earnings floor. Management's H2 2026 agenda includes the ~$1.7 billion Q3 guide, more than $500 million of working capital release, the $60 million Barry uplift, and the start of quarterly headcount disclosures. Beyond that, Bohlen is on track for 2027 and Alberta Path2Zero remains a late-2029 growth project.
- Q3 2026Q3 2026 earnings report — Tests ~$1.7B EBITDA guide against PE pricing and maintenance completions.
- H2 2026Working capital release — Tests management's expected >$500M release.
- H2 2026Barry shutdown uplift — Tests expected $60M EBITDA uplift from siloxane capacity removal.
- H2 2026Quarterly headcount disclosure — First measurable check on Transform to Outperform delivery.
- 2027Bohlen cracker shutdown — Tests completed shutdown and European cost-position improvement.
- Late 2029Alberta Path2Zero startup — Tests late-2029 schedule, remaining 40% of CapEx, and return threshold.
Financials
Annual Summary
| Metric | FY2024 | FY2025 | TTM | YoY |
|---|---|---|---|---|
| Revenue | $43.0B | $40.0B | $41.3B | -7.0% |
| Gross Margin | 10.3% | 6.2% | 9.8% | 412bps |
| EBITDA | $4.9B | $2.1B | $56.6B | -57.6% |
| EBITDA Margin | 11.5% | 5.2% | 6.6% | 627bps |
| Net Income | $1.1B | −$2.6B | −$1.2B | -335.0% |
| Free Cash Flow | −$151M | −$2.6B | $21.6B | — |
| Net Cash | — | — | — | — |
Key Ratios (Trailing)
- P/E TTM—
- EV/EBITDA TTM—
- EV/Revenue TTM—
- Price/FCF TTM—
- Gross Margin (TTM)9.8%
- EBITDA Margin (TTM)6.6%
- Net Margin (TTM)-2.9%
- ROIC-0.1%
- FCF Conversion15.9%
- SBC / Revenue0.0%
The Company
Dow is a global materials science company organized into Packaging & Specialty Plastics, Industrial Intermediates & Infrastructure, and Performance Materials & Coatings. It makes ethylene, polyethylene, propylene oxide, polyether polyols, silicones, coatings, and intermediate chemicals used across packaging, infrastructure, mobility, and consumer applications. In the AI infrastructure buildout, its most visible products are thermal management materials and cooling-service models for data centers, plus silicones for electronics.
Dow operates manufacturing sites in 29 countries and employs approximately 34,600 people. Management says more than 60% of assets are in feedstock-advantaged regions, and roughly 80% of P&SP product sales go into higher-value applications including packaging, consumer, and health and hygiene. Its plant list spans Argentina, Canada, China, the Netherlands, Thailand, and the United States, with U.S. Gulf Coast, Canadian, and Argentine assets central to its Americas cost advantage.
Business Segments
Competitive Landscape
Dow's 10-K positions it as a leading global producer of ethylene, a recognized leader in polyethylene, and the world's largest producer of propylene oxide, propylene glycol, and polyether polyols. Competitor read-throughs in the supplied materials are limited; Huntsman and Celanese offer cautionary reads on demand destruction and end-use demand amid the conflict-driven pricing surge.
- HuntsmanCited in the supplied intel file for 'euphoria' caution on demand destruction as rapid price increases hit end demand.
- CelaneseCited in the supplied intel file for the caution that demand continues to be low at an end-use level.
Supply Chain
Dow sits mid-chain in petrochemicals and advanced materials, buying feedstock and energy and selling into packaging, construction, mobility, electronics, and data-center cooling.
More on DOW: Earnings recap